CN106491909A - A kind of Chinese medicine for treating Childhood Nephrotic Syndrome - Google Patents
A kind of Chinese medicine for treating Childhood Nephrotic Syndrome Download PDFInfo
- Publication number
- CN106491909A CN106491909A CN201710020941.5A CN201710020941A CN106491909A CN 106491909 A CN106491909 A CN 106491909A CN 201710020941 A CN201710020941 A CN 201710020941A CN 106491909 A CN106491909 A CN 106491909A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- fructus
- nephrotic syndrome
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 206010029164 Nephrotic syndrome Diseases 0.000 title claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 210000003038 endothelium Anatomy 0.000 claims abstract description 20
- 239000009636 Huang Qi Substances 0.000 claims abstract description 14
- 241001251068 Formica fusca Species 0.000 claims abstract description 13
- 241000756943 Codonopsis Species 0.000 claims abstract description 12
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000000052 vinegar Substances 0.000 claims description 12
- 235000021419 vinegar Nutrition 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 235000015099 wheat brans Nutrition 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 239000000080 wetting agent Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 238000002386 leaching Methods 0.000 claims 1
- 239000002893 slag Substances 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 210000002435 tendon Anatomy 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract 1
- 235000009508 confectionery Nutrition 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 5
- 208000017169 kidney disease Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010015993 Eyelid oedema Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000001861 immunosuppressant effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010061819 Disease recurrence Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 231100000852 glomerular disease Toxicity 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- -1 granulation to dry Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940125698 hormone suppressant Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a kind of Chinese medicine for treating Childhood Nephrotic Syndrome, it is related to the field of Chinese medicines, the raw material of the Chinese medicine is by 15 30 parts of Herba Epimedii, 5 15 parts of the Cortex Eucommiae, 10 25 parts of the Radix Astragali, 8 15 parts of Fructus Ligustri Lucidi, 6 12 parts of the Rhizoma Atractylodis Macrocephalae, 5 12 parts of Endothelium Corneum Gigeriae Galli, 5 15 parts of Formica fusca, 10 15 parts of Rhizoma Dioscoreae, 10 15 parts of Fructus Crataegi, 5 10 parts of Radix Glycyrrhizae, 8 12 parts of Fructus Lycii, 5 10 parts of Radix Codonopsis, 38 parts of Fructus Jujubae ratio composition by weight, by the treatment of the Chinese medicine, kidney and spleen invigorating can be played, vigorate qi and replenish the blood, effect of strengthening the tendons and bones, and the immunity of child can be strengthened, preventing and treating recurrence and delay, the side effect for avoiding Western medicine from producing.
Description
Technical field
The present invention relates to the field of Chinese medicines, and in particular to a kind of Chinese medicine for treating Childhood Nephrotic Syndrome.
Background technology
Childhood Nephrotic Syndrome is a kind of chronic disease, is one group of clinical syndrome in renal glomerular disease, and typical performance is a large amount of eggs
Albiduria, hypoproteinemia, edema or with hyperlipidemia, treatment is got up relatively difficult, easily recurrence and delays, the course of disease during treatment
Long.
At present, the clinical Therapeutic Method to Childhood Nephrotic Syndrome is mainly hormonal medicaments and immunosuppressant therapeutic alliance, but
The side effect that hormone is produced is very big, and due to Long-term Hormone, easy secondary infection common are skin infection, respiratory tract sense
Dye, primary peritonitis etc., what harm was maximum is viral infection, especially during hormone or immunosuppressant treatment, concurrently
Often serious than normal children when measles, chickenpox, herpes zoster.Up to the present, the herbal treatment of Childhood Nephrotic Syndrome is studied also very
Few, Chinese medicine can be prevented effectively from the side effect produced by Western medicine, being reduced to minimum to the actual bodily harm of child.
Content of the invention
(1) technical problem for solving
For the deficiencies in the prior art, the invention provides a kind of Chinese medicine for treating Childhood Nephrotic Syndrome, its Small side effects.
(2) technical scheme
For realizing that object above, the present invention are achieved by the following technical programs：
A kind of Chinese medicine for treating Childhood Nephrotic Syndrome, the Chinese medicine are made up of following raw materials by weight portion ratio：Herba Epimedii 15-
30 parts, Cortex Eucommiae 5-15 part, Radix Astragali 10-25 parts, Fructus Ligustri Lucidi 8-15 parts, Rhizoma Atractylodis Macrocephalae 6-12 parts, Endothelium Corneum Gigeriae Galli 5-12 parts, Formica fusca 5-15 parts,
Rhizoma Dioscoreae 10-15 parts, Fructus Crataegi 10-15 parts, Radix Glycyrrhizae 5-10 parts, Fructus Lycii 8-12 parts, Radix Codonopsis 5-10 parts, Fructus Jujubae 3-8 parts.
Preferably, the Chinese medicine is made up of following raw materials by weight portion ratio：20 parts of Herba Epimedii, 8 parts of the Cortex Eucommiae, the Radix Astragali 15
Part, 10 parts of Fructus Ligustri Lucidi, 8 parts of the Rhizoma Atractylodis Macrocephalae, 8 parts of Endothelium Corneum Gigeriae Galli, 7 parts of Formica fusca, 12 parts of Rhizoma Dioscoreae, 13 parts of Fructus Crataegi, 8 parts of Radix Glycyrrhizae, 10 parts of Fructus Lycii, party
7 parts of ginseng, 4 parts of Fructus Jujubae.
Preferably, the Chinese medicine is made up of following raw materials by weight portion ratio：25 parts of Herba Epimedii, 12 parts of the Cortex Eucommiae, the Radix Astragali
18 parts, 9 parts of Fructus Ligustri Lucidi, 10 parts of the Rhizoma Atractylodis Macrocephalae, 8 parts of Endothelium Corneum Gigeriae Galli, 9 parts of Formica fusca, 14 parts of Rhizoma Dioscoreae, 12 parts of Fructus Crataegi, 7 parts of Radix Glycyrrhizae, 8 parts of Fructus Lycii,
6 parts of Radix Codonopsis, 7 parts of Fructus Jujubae.
Preferably, the Chinese medicine is made up of following raw materials by weight portion ratio：15 parts of Herba Epimedii, 5 parts of the Cortex Eucommiae, the Radix Astragali 25
Part, 8 parts of Fructus Ligustri Lucidi, 6 parts of the Rhizoma Atractylodis Macrocephalae, 12 parts of Endothelium Corneum Gigeriae Galli, 5 parts of Formica fusca, 10 parts of Rhizoma Dioscoreae, 10 parts of Fructus Crataegi, 5 parts of Radix Glycyrrhizae, 9 parts of Fructus Lycii, party
5 parts of ginseng, 8 parts of Fructus Jujubae.
Preferably, the Chinese medicine is made up of following raw materials by weight portion ratio：30 parts of Herba Epimedii, 15 parts of the Cortex Eucommiae, the Radix Astragali
10 parts, 15 parts of Fructus Ligustri Lucidi, 12 parts of the Rhizoma Atractylodis Macrocephalae, 5 parts of Endothelium Corneum Gigeriae Galli, 15 parts of Formica fusca, 15 parts of Rhizoma Dioscoreae, 15 parts of Fructus Crataegi, 10 parts of Radix Glycyrrhizae, Fructus Lycii 12
Part, 10 parts of Radix Codonopsis, 3 parts of Fructus Jujubae.
Preferably, the Chinese medicine is described preparation on any pharmaceuticss.
Preferably, the preparation method of the Chinese medicine is comprised the following steps：(1) taken out, sieve to faint yellow with wheat bran Rhizoma Atractylodis Macrocephalae (parched)
Wheat bran is removed, is cooled；(2) take Fructus Ligustri Lucidi and Endothelium Corneum Gigeriae Galli is added in vinegar, stirring, heating during vinegar to be painted, is taken out, dried；(3) will step
The water of raw material 12 times of the dosing material gross weight together with other described raw materials after (1) and (2) is processed suddenly, decocts 3 hours；(4) mistake
Filter filtrate, the water that medicinal residues are added 8 times of medical material gross weight decoct 2 hours；(5) filter, merge filtrate twice, filtrate is concentrated
Extractum of the relative density for 1.15-1.25 to room temperature；(6) sucrose, dextrin mixing, plus ethanol is added to moisten the extractum
Agent, granulation, dry, granulate are obtained granule, or tabletting is obtained tablet agent；Or add Lactose, Mel to be obtained the extractum
Pill.
(3) beneficial effect
In this prescription, raw materials used major function is as follows：
Herba Epimedii acrid in the mouth, sweet, warm in nature, liver kidney two warp is walked, is the medicine of beneficial vital essence, bone and muscle strengthening, can be with blood pressure lowering blood sugar lowering, increase
Cardiovascular and cerebrovascular vessel blood flow, promotion immunologic function.
Cortex Eucommiae acrid in the mouth, puts down,《Compendium of Materia Medica》Described in：Cortex Eucommiae color is purple and moisten, sweet in the mouth micro-pungent, its temperature is flat, and sweet temperature can be mended,
Micro-pungent can be moistened, therefore can enter liver and the kidney invigorating.
Radix Astragali sweet in the mouth, tepor, return lung, spleen, liver and kidney channel, air making-up and spleen enlivening can treat acute nephritis edema, chronic nephritiss
Edema, spleen kidney deficiency, the deficiency of vital energy are weak.
Fructus Ligustri Lucidi is bitter, cool, returns liver and kidney channel, and tonification liver and gall, improving eyesight, clearind deficient heat, the invigorating the liver and kidney efficacy of a drug are gentle.
Rhizoma Atractylodis Macrocephalae sweet in the mouth, such as slight bitter, stomach of foot Yang Ming, spleen meridian.Invigorating middle warmer dampness, slakes thirst and help produce saliva, and most strengthening the spleen is passed through, big nourishing the stomach
Gas.
Endothelium Corneum Gigeriae Galli sweet taste, does not disappear for food stagnation, vomiting dysentery, infantile malnutrition.
Formica fusca the kidney invigorating and essence nourishing, dredge the meridian passage, removing toxic substances and promoting subsidence of swelling.
Rhizoma Dioscoreae contains the materials such as mucoprotein, amylase, saponin, free amino acid, polyphenol oxidase, and content is more rich
Richness, with tonic effect, is the good merchantable brand of rehabilitation tonic after being ill, plays the role of strong body, kidney nourishing and replenishing vital essence.
Fructus Crataegi nature and flavor acid is sweet, tepor, has aid digestion, blood fat reducing, resists myocardial ischemia, strengthens myocardial contraction, antioxidative
Effect.
Radix Glycyrrhizae has antiinflammatory, anti-allergic effects, and can coordinating the actions of various ingredients in a prescription in side.
Fructus Lycii nourishing the liver, nourishing kidney, lung moistening.
Radix Codonopsis invigorating the spleen and replenishing QI, clearing heat and detoxicating, expelling phlegm for arresting cough.
Fructus Jujubae sweet in the mouth is warm in nature, returns spleen stomach, has invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind, the function of relaxing the property of medicine.
The Chinese medicine of the treatment Childhood Nephrotic Syndrome that the present invention is provided, can play a part of kidney and spleen invigorating, and can strengthen
Virgin immunity, strengthening the tendons and bones reduce side effect.
Specific embodiment
Purpose, technical scheme and advantage for making the embodiment of the present invention is clearer, below in conjunction with the embodiment of the present invention,
Technical scheme in the embodiment of the present invention is clearly and completely described, it is clear that described embodiment is the present invention one
Divide embodiment, rather than whole embodiments.Embodiment in based on the present invention, those of ordinary skill in the art are not being made
The every other embodiment obtained under the premise of creative work, belongs to the scope of protection of the invention.
Embodiment 1：
A kind of Chinese medicine for treating Childhood Nephrotic Syndrome, the Chinese medicine are made up of following raw materials by weight portion ratio：Herba Epimedii 20
Part, 8 parts of the Cortex Eucommiae, 15 parts of the Radix Astragali, 10 parts of Fructus Ligustri Lucidi, 8 parts of the Rhizoma Atractylodis Macrocephalae, 8 parts of Endothelium Corneum Gigeriae Galli, 7 parts of Formica fusca, 12 parts of Rhizoma Dioscoreae, 13 parts of Fructus Crataegi are sweet
8 parts of grass, 10 parts of Fructus Lycii, 7 parts of Radix Codonopsis, 4 parts of Fructus Jujubae.Its preparation method is comprised the following steps：
(1) taken out, weed out wheat bran, cool to faint yellow with wheat bran Rhizoma Atractylodis Macrocephalae (parched)；(2) take Fructus Ligustri Lucidi and Endothelium Corneum Gigeriae Galli adds vinegar
In, stirring, heating during vinegar to be painted, are taken out, are dried；(3) raw material and other described raw materials one after processing step (1) and (2)
The water of 12 times of dosing material gross weight is played, is decocted 3 hours；(4) filter liquor, the water that medicinal residues are added 8 times of medical material gross weight are decocted
2 hours；(5) filter, merge filtrate twice, concentrate the filtrate to extractum of the relative density for 1.15-1.25 under room temperature；(6) will
The extractum adds sucrose, dextrin mixing, plus ethanol to make wetting agent, and granulation, dry, granulate are obtained granule.
Embodiment 2：
A kind of Chinese medicine for treating Childhood Nephrotic Syndrome, the Chinese medicine are made up of following raw materials by weight portion ratio：Herba Epimedii 25
Part, 12 parts of the Cortex Eucommiae, 18 parts of the Radix Astragali, 9 parts of Fructus Ligustri Lucidi, 10 parts of the Rhizoma Atractylodis Macrocephalae, 8 parts of Endothelium Corneum Gigeriae Galli, 9 parts of Formica fusca, 14 parts of Rhizoma Dioscoreae, 12 parts of Fructus Crataegi,
7 parts of Radix Glycyrrhizae, 8 parts of Fructus Lycii, 6 parts of Radix Codonopsis, 7 parts of Fructus Jujubae.Its preparation method is comprised the following steps：
(1) taken out, weed out wheat bran, cool to faint yellow with wheat bran Rhizoma Atractylodis Macrocephalae (parched)；(2) take Fructus Ligustri Lucidi and Endothelium Corneum Gigeriae Galli adds vinegar
In, stirring, heating during vinegar to be painted, are taken out, are dried；(3) raw material and other described raw materials one after processing step (1) and (2)
The water of 12 times of dosing material gross weight is played, is decocted 3 hours；(4) filter liquor, the water that medicinal residues are added 8 times of medical material gross weight are decocted
2 hours；(5) filter, merge filtrate twice, concentrate the filtrate to extractum of the relative density for 1.15-1.25 under room temperature；(6) will
The extractum adds sucrose, dextrin mixing, plus ethanol to make wetting agent, and granulation, dry, granulate, tabletting are obtained tablet.
Embodiment 3：
A kind of Chinese medicine for treating Childhood Nephrotic Syndrome, the Chinese medicine are made up of following raw materials by weight portion ratio：Herba Epimedii 15
Part, 5 parts of the Cortex Eucommiae, 25 parts of the Radix Astragali, 8 parts of Fructus Ligustri Lucidi, 6 parts of the Rhizoma Atractylodis Macrocephalae, 12 parts of Endothelium Corneum Gigeriae Galli, 5 parts of Formica fusca, 10 parts of Rhizoma Dioscoreae, 10 parts of Fructus Crataegi are sweet
5 parts of grass, 9 parts of Fructus Lycii, 5 parts of Radix Codonopsis, 8 parts of Fructus Jujubae.Its preparation method is comprised the following steps：
(1) taken out, weed out wheat bran, cool to faint yellow with wheat bran Rhizoma Atractylodis Macrocephalae (parched)；(2) take Fructus Ligustri Lucidi and Endothelium Corneum Gigeriae Galli adds vinegar
In, stirring, heating during vinegar to be painted, are taken out, are dried；(3) raw material and other described raw materials one after processing step (1) and (2)
The water of 12 times of dosing material gross weight is played, is decocted 3 hours；(4) filter liquor, the water that medicinal residues are added 8 times of medical material gross weight are decocted
2 hours；(5) filter, merge filtrate twice, concentrate the filtrate to extractum of the relative density for 1.15-1.25 under room temperature；(6) will
The extractum adds Lactose, Mel mixing, plus ethanol to make wetting agent, and honey pill agent is obtained with modeling preparation method.
Embodiment 4：
A kind of Chinese medicine for treating Childhood Nephrotic Syndrome, the Chinese medicine are made up of following raw materials by weight portion ratio：Herba Epimedii 30
Part, 15 parts of the Cortex Eucommiae, 10 parts of the Radix Astragali, 15 parts of Fructus Ligustri Lucidi, 12 parts of the Rhizoma Atractylodis Macrocephalae, 5 parts of Endothelium Corneum Gigeriae Galli, 15 parts of Formica fusca, 15 parts of Rhizoma Dioscoreae, Fructus Crataegi 15
Part, 10 parts of Radix Glycyrrhizae, 12 parts of Fructus Lycii, 10 parts of Radix Codonopsis, 3 parts of Fructus Jujubae.Its preparation method is comprised the following steps：
(1) taken out, weed out wheat bran, cool to faint yellow with wheat bran Rhizoma Atractylodis Macrocephalae (parched)；(2) take Fructus Ligustri Lucidi and Endothelium Corneum Gigeriae Galli adds vinegar
In, stirring, heating during vinegar to be painted, are taken out, are dried；(3) raw material and other described raw materials one after processing step (1) and (2)
The water of 12 times of dosing material gross weight is played, is decocted 3 hours；(4) filter liquor, the water that medicinal residues are added 8 times of medical material gross weight are decocted
2 hours；(5) filter, merge filtrate twice, concentrate the filtrate to extractum of the relative density for 1.15-1.25 under room temperature；(6) will
The extractum adds sucrose, dextrin, granulation to dry, granulate, loads capsule and capsule is obtained.
The acute toxicity test of the present invention：
Take the male and female white mice that body weight is 15-20g each 20, feeding wants one week its body indices Pass Test
Ask, after fasting 12 hours, Chinese medicine obtained in embodiment 1 is given according to 0.5mg/10g gavages, press 0.5mg/10g agent after 2 hours again
Amount administration, Continuous Observation 10 days, none are only dead, observe the organs such as its heart, liver, spleen, lung, kidney and have no significant change after dissection.
It is indicated above that acute toxicity test has no obvious toxic-side effects.
Clinical trial：
The age Childhood Nephrotic Syndrome patient between 2-14 year 80 is chosen, is divided into matched group and experimental group, per group each 40,
Every group of sex covers men and women, and age differencess do not have statistical significance.
Matched group adopts glucocorticoid therapy, experimental group using obtained granule in the embodiment of the present invention 1,10 years old with
Upper child each takes 2g, and three times a day, 5-10 year child each takes 1g, and three times a day, 2-5 year child takes 0.5g daily,
Three times a day, course for the treatment of one week, takes 4 courses for the treatment of.
After treatment, statistical analysiss, P is carried out with SPSS 13.0<0.05 represents that there is significant.Matched group effective percentage
It is 72.5%, treatment group's effective percentage is 92.5%, and the two is compared, the therapeutic effect for the treatment of group is substantially better than matched group.
Typical case：
1st, certain man, 6 years old, nephropathy symptom showed as edema, fatigue and weakness, lethargy, loss of appetite, took of the invention real
Chinese medicine obtained in example 1 is applied after 2 weeks, edema has mitigated, appetite increases, and after taking 4 weeks, edema disappears substantially, diet just recovers
Often, weak sense is eliminated, in high spirits.
2nd, certain female, 10 years old, nephropathy symptom showed as hypertension, nausea, dizziness, vomiting, hematuria, loss of appetite, took this
After 4 weeks, blood pressure is decreased obviously Chinese medicine obtained in inventive embodiments 2, and the symptom such as Nausea and vomiting, hematuria disappears, and appetite increases.
3rd, certain female, 3 years old, nephropathy symptom showed as low grade fever, dizzy faintness, upper eyelid edema, hypoevolutism, dysphoria,
Chinese medicine obtained in the embodiment of the present invention 3 is taken after 5 weeks, low grade fever is disappeared, do not have dizzy faintness phenomenon, upper eyelid edema to disappear, no
Irritated again.
4th, certain man, 10 years old, nephropathy symptom showed as skin and purple striae occurs, and frequent micturition, albuminuria, the withered Huang of hair are withered, anemia,
Inappetence, took Chinese medicine obtained in the embodiment of the present invention 4 after 5 weeks, and urine protein is significantly reduced, and skin purple striae disappears, routine blood test
Check that indices are normal.
To sum up, the embodiment of the present invention has the advantages that：
The Chinese medicine has a significant effect to the nephropathy for treating child, and can avoid the side effect that Western medicine produces, preferably
Prevent disease recurrence and delay.
It should be noted that herein, such as first and second or the like relational terms are used merely to a reality
Body or operation are made a distinction with another entity or operation, and are not necessarily required or implied these entities or deposit between operating
In any this actual relation or order.And, term " including ", "comprising" or its any other variant are intended to
Nonexcludability includes, so that a series of process, method, article or equipment including key elements not only includes that those will
Element, but also other key elements including being not expressly set out, or also include for this process, method, article or equipment
Intrinsic key element.In the absence of more restrictions, the key element for being limited by sentence "including a ...", it is not excluded that
Also there is other identical element in process, method, article or equipment including the key element.
Above example only in order to technical scheme to be described, rather than a limitation；Although with reference to the foregoing embodiments
The present invention has been described in detail, it will be understood by those within the art that：Which still can be to aforementioned each enforcement
Technical scheme described in example is modified, or carries out equivalent to which part technical characteristic；And these modification or
Replace, do not make the essence of appropriate technical solution depart from the spirit and scope of various embodiments of the present invention technical scheme.
Claims (5)
1. a kind of Chinese medicine for treating Childhood Nephrotic Syndrome, it is characterised in that the Chinese medicine is made up of following raw materials by weight portion ratio：
Herba Epimedii 15-30 parts, Cortex Eucommiae 5-15 part, Radix Astragali 10-25 parts, Fructus Ligustri Lucidi 8-15 parts, Rhizoma Atractylodis Macrocephalae 6-12 parts, Endothelium Corneum Gigeriae Galli 5-12 parts, ant
Ant 5-15 parts, Rhizoma Dioscoreae 10-15 parts, Fructus Crataegi 10-15 parts, Radix Glycyrrhizae 5-10 parts, Fructus Lycii 8-12 parts, Radix Codonopsis 5-10 parts, Fructus Jujubae 3-8 parts.
2. a kind of Chinese medicine for treating Childhood Nephrotic Syndrome, it is characterised in that the Chinese medicine is made up of following raw materials by weight portion ratio：
20 parts of Herba Epimedii, 8 parts of the Cortex Eucommiae, 15 parts of the Radix Astragali, 10 parts of Fructus Ligustri Lucidi, 8 parts of the Rhizoma Atractylodis Macrocephalae, 8 parts of Endothelium Corneum Gigeriae Galli, 7 parts of Formica fusca, 12 parts of Rhizoma Dioscoreae, mountain
13 parts of short, bristly hair or beard, 8 parts of Radix Glycyrrhizae, 10 parts of Fructus Lycii, 7 parts of Radix Codonopsis, 4 parts of Fructus Jujubae.
3. a kind of Chinese medicine for treating Childhood Nephrotic Syndrome, it is characterised in that the Chinese medicine is made up of following raw materials by weight portion ratio：
25 parts of Herba Epimedii, 12 parts of the Cortex Eucommiae, 18 parts of the Radix Astragali, 9 parts of Fructus Ligustri Lucidi, 10 parts of the Rhizoma Atractylodis Macrocephalae, 8 parts of Endothelium Corneum Gigeriae Galli, 9 parts of Formica fusca, 14 parts of Rhizoma Dioscoreae, mountain
12 parts of slag, 7 parts of Radix Glycyrrhizae, 8 parts of Fructus Lycii, 6 parts of Radix Codonopsis, 7 parts of Fructus Jujubae.
4. as described in claim 1 treatment Childhood Nephrotic Syndrome Chinese medicine, it is characterised in that the Chinese medicine is any medicament
Described preparation on.
5. the Chinese medicine for the treatment of Childhood Nephrotic Syndrome as claimed in claim 1, its preparation method comprises the following steps：(1) fried with wheat bran
The Rhizoma Atractylodis Macrocephalae is taken out, weeds out wheat bran, cool to faint yellow；(2) take Fructus Ligustri Lucidi and Endothelium Corneum Gigeriae Galli is added in vinegar, stirring, heating, vinegar to be painted
When, take out, dry；(3) 12 times of the dosing material gross weight together with other described raw materials of the raw material after processing step (1) and (2)
Water, decoct 3 hours；(4) filter liquor, the water that medicinal residues are added 8 times of medical material gross weight are decocted 2 hours；(5) filter, merge
Filtrate, concentrates the filtrate to extractum of the relative density for 1.15-1.25 under room temperature twice；(6) extractum is added sucrose, paste
Essence mixes, plus ethanol makees wetting agent, and granulation, dry, granulate are obtained granule, or tabletting is obtained tablet agent；Or by the leaching
Cream adds Lactose, Mel that pill is obtained.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710020941.5A CN106491909A (en) | 2017-01-11 | 2017-01-11 | A kind of Chinese medicine for treating Childhood Nephrotic Syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710020941.5A CN106491909A (en) | 2017-01-11 | 2017-01-11 | A kind of Chinese medicine for treating Childhood Nephrotic Syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106491909A true CN106491909A (en) | 2017-03-15 |
Family
ID=58345286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710020941.5A Pending CN106491909A (en) | 2017-01-11 | 2017-01-11 | A kind of Chinese medicine for treating Childhood Nephrotic Syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106491909A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107582983A (en) * | 2017-10-01 | 2018-01-16 | 河南科技大学第附属医院 | A kind of Chinese medicine for treating Childhood Nephrotic Syndrome and preparation method thereof |
| CN110064016A (en) * | 2019-06-14 | 2019-07-30 | 陕西中医药大学 | A kind of Chinese medicine composition and preparation method thereof adjusting chronic kidney disease immune state |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062245A (en) * | 2007-06-07 | 2007-10-31 | 张德勇 | Chinese traditional medicine agent for treating children nephropathy syndrome |
| CN104353047A (en) * | 2014-11-24 | 2015-02-18 | 时成伍 | Traditional Chinese medicine for treating nephritis |
-
2017
- 2017-01-11 CN CN201710020941.5A patent/CN106491909A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062245A (en) * | 2007-06-07 | 2007-10-31 | 张德勇 | Chinese traditional medicine agent for treating children nephropathy syndrome |
| CN104353047A (en) * | 2014-11-24 | 2015-02-18 | 时成伍 | Traditional Chinese medicine for treating nephritis |
Non-Patent Citations (1)
| Title |
|---|
| 熊小丽等: "小儿肾病综合征的中医药治疗进展", 《刘弼臣教授从医六十五周年学术思想研讨会暨中华中医药学会儿科分会与全国中医药高等教育学会儿科分会全国学术交流大会论文汇编》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107582983A (en) * | 2017-10-01 | 2018-01-16 | 河南科技大学第附属医院 | A kind of Chinese medicine for treating Childhood Nephrotic Syndrome and preparation method thereof |
| CN110064016A (en) * | 2019-06-14 | 2019-07-30 | 陕西中医药大学 | A kind of Chinese medicine composition and preparation method thereof adjusting chronic kidney disease immune state |
| CN110064016B (en) * | 2019-06-14 | 2022-02-01 | 陕西中医药大学 | Traditional Chinese medicine composition for regulating immune state of chronic kidney disease and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101628068A (en) | Pharmaceutical composition for treating juvenile poliosis and preparation method thereof | |
| CN105920514A (en) | Traditional Chinese medicinal composition for treating metabolic syndrome | |
| CN106491909A (en) | A kind of Chinese medicine for treating Childhood Nephrotic Syndrome | |
| CN104856036B (en) | Health care medicated diet for treating iron-deficiency anemia and preparation method of health care medicated diet | |
| CN101095798B (en) | Chinese traditional medicine for treating canities | |
| CN105687788A (en) | Pharmaceutical composition capable of softening blood vessels and application thereof | |
| CN104825821A (en) | Medicine for treating diabetes and preparation method thereof | |
| CN105796755A (en) | Traditional Chinese medicinal composition for treating diabetic nephropathy | |
| CN106165794A (en) | A kind of supplementing QI and nourishing YIN dispelling wind collaterals-dredgingdrink drink and preparation processing method | |
| CN105311470A (en) | Application of pharmaceutical composition containing folium artemisiae argyi in preparing medicine for treating diabetic nephropathy | |
| CN104800600A (en) | Medicine for treating hypertension | |
| CN104857121A (en) | Drug combination for curing hyperlipidemia and application thereof | |
| CN110420297A (en) | A kind of Chinese materia medica preparation for anti-trioxypurine | |
| CN108785575A (en) | A kind of Chinese herbal ointment formula | |
| CN104547859A (en) | Application of traditional Chinese medicine preparation in preparation of medicine for treating chronic tracheitis | |
| CN114588228B (en) | Composition for treating type 2 diabetes | |
| CN106165749A (en) | One treats deficient qi and blood anemia medicated tea and preparation processing method | |
| CN106038994A (en) | Food medicine for assisting in blood glucose reducing and preparation method thereof | |
| CN106177404A (en) | A kind of Chinese medicine composition treating the hepatic and renal YIN deficiency and preparation method thereof | |
| CN105878901A (en) | Traditional Chinese medicine preparation for treating skin flap necrosis after breast cancer operation and preparation method | |
| CN104958689A (en) | Application of traditional Chinese medicinal composition in preparation of medicine for treating chronic gastritis | |
| CN104922301A (en) | Traditional Chinese medicine preparation for gastric mucosa prolapse syndrome and preparation method of traditional Chinese medicine preparation | |
| CN111686207A (en) | Dendrobium devonianum compound preparation and preparation method and application thereof | |
| CN112587613A (en) | A composition for treating diabetes and preparation method thereof | |
| CN114796417A (en) | Traditional Chinese medicine formula for reducing blood sugar and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170315 |